LIVANOVA PLC (LIVN) Stock Fundamental Analysis
USA - NASDAQ:LIVN - GB00BYMT0J19 - Common Stock
52.72 USD
-0.07 (-0.13%)
Overall LIVN gets a fundamental rating of 5 out of 10. We evaluated LIVN against 189 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year LIVN was profitable.
LIVN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
LIVN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
LIVN has a Return On Assets of -8.43%. This is in the better half of the industry: LIVN outperforms 63.49% of its industry peers.
LIVN has a Return On Equity (-18.82%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 8.04%, LIVN belongs to the top of the industry, outperforming 86.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 9.01%.
The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.04%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROIC | 8.04% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
LIVN's Operating Margin of 14.41% is amongst the best of the industry. LIVN outperforms 83.60% of its industry peers.
In the last couple of years the Operating Margin of LIVN has grown nicely.
LIVN has a better Gross Margin (69.07%) than 76.72% of its industry peers.
LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% |
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LIVN has been increased compared to 1 year ago.
LIVN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LIVN has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.46, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
LIVN has a Altman-Z score (1.46) which is in line with its industry peers.
The Debt to FCF ratio of LIVN is 2.66, which is a good value as it means it would take LIVN, 2.66 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LIVN (2.66) is better than 87.83% of its industry peers.
LIVN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
LIVN's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. LIVN outperforms 50.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Altman-Z | 1.46 |
ROIC/WACC0.94
WACC8.59%
2.3 Liquidity
LIVN has a Current Ratio of 1.29. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, LIVN is not doing good in the industry: 78.84% of the companies in the same industry are doing better.
LIVN has a Quick Ratio of 1.09. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, LIVN is doing worse than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.66%, which is quite good.
The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.23% in the last year.
LIVN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.94% yearly.
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
3.2 Future
LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.46% yearly.
The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y13.5%
EPS Next 2Y11.34%
EPS Next 3Y10.39%
EPS Next 5Y11.46%
Revenue Next Year8.58%
Revenue Next 2Y8.2%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.48, the valuation of LIVN can be described as correct.
LIVN's Price/Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 86.77% of the companies in the same industry.
LIVN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.19.
A Price/Forward Earnings ratio of 12.62 indicates a correct valuation of LIVN.
LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.50. LIVN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.48 | ||
| Fwd PE | 12.62 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 85.19% of the companies listed in the same industry.
88.36% of the companies in the same industry are more expensive than LIVN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.76 | ||
| EV/EBITDA | 11.73 |
4.3 Compensation for Growth
LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.07
PEG (5Y)7.98
EPS Next 2Y11.34%
EPS Next 3Y10.39%
5. Dividend
5.1 Amount
No dividends for LIVN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:LIVN (10/31/2025, 9:49:03 AM)
52.72
-0.07 (-0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.79%
Inst Owner Change-0.56%
Ins Owners0.28%
Ins Owner Change3.6%
Market Cap2.88B
Revenue(TTM)1.31B
Net Income(TTM)-211317000
Analysts82.5
Price Target64.9 (23.1%)
Short Float %3.56%
Short Ratio3.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.73%
Min EPS beat(2)13.16%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)13.91%
Min EPS beat(4)-0.89%
Max EPS beat(4)23.08%
EPS beat(8)7
Avg EPS beat(8)17.82%
EPS beat(12)11
Avg EPS beat(12)17.01%
EPS beat(16)14
Avg EPS beat(16)16.29%
Revenue beat(2)2
Avg Revenue beat(2)3.38%
Min Revenue beat(2)2.76%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)3.36%
Revenue beat(16)13
Avg Revenue beat(16)2.63%
PT rev (1m)0%
PT rev (3m)3.92%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)1.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2.88%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)3.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.48 | ||
| Fwd PE | 12.62 | ||
| P/S | 2.2 | ||
| P/FCF | 17.76 | ||
| P/OCF | 13.29 | ||
| P/B | 2.56 | ||
| P/tB | 31.87 | ||
| EV/EBITDA | 11.73 |
EPS(TTM)3.64
EY6.9%
EPS(NY)4.18
Fwd EY7.92%
FCF(TTM)2.97
FCFY5.63%
OCF(TTM)3.97
OCFY7.52%
SpS23.98
BVpS20.56
TBVpS1.65
PEG (NY)1.07
PEG (5Y)7.98
Graham Number41.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROCE | 11.23% | ||
| ROIC | 8.04% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 252.77% | ||
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% | ||
| FCFM | 12.38% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 126.11% | ||
| Cap/Sales | 4.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 93.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.46 |
F-Score6
WACC8.59%
ROIC/WACC0.94
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
EPS Next Y13.5%
EPS Next 2Y11.34%
EPS Next 3Y10.39%
EPS Next 5Y11.46%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
Revenue Next Year8.58%
Revenue Next 2Y8.2%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%
EBIT growth 1Y77.01%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year34.28%
EBIT Next 3Y14.67%
EBIT Next 5Y3.21%
FCF growth 1Y465.94%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y278.91%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
What is the valuation status for LIVN stock?
ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.
How profitable is LIVANOVA PLC (LIVN) stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the valuation of LIVANOVA PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LIVANOVA PLC (LIVN) is 14.48 and the Price/Book (PB) ratio is 2.56.
How financially healthy is LIVANOVA PLC?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.